Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Risk Factors of the Totally Implantable Venous Access Device-Related Infection in Patients With Brain Tumors Undergoing Chemotherapy After Surgery.

  • Authors : Li H; Department of Neurosurgery 1, Cangzhou Central Hospital, Cangzhou, Hebei, China.; Shan J

Subjects: Catheterization, Central Venous*/Catheterization, Central Venous*/Catheterization, Central Venous*/adverse effects ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/etiology

  • Source: Surgical infections [Surg Infect (Larchmt)] 2024 Mar; Vol. 25 (2), pp. 133-139. Date of Electronic Publication: 2024 Jan 23.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9815642 Publication Model: Print-Electronic

Record details

×
Academic Journal

Therapeutic Hypothermia in Treating Glioblastoma: A Review.

  • Authors : Malliou A; Neurosurgical Institute, University of Ioannina, Ioannina, Greece.; Mitsiou C

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Hypothermia*/Hypothermia*/Hypothermia*/therapy

  • Source: Therapeutic hypothermia and temperature management [Ther Hypothermia Temp Manag] 2024 Mar; Vol. 14 (1), pp. 2-9. Date of Electronic Publication: 2023 May 15.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101543518 Publication Model: Print-Electronic

Record details

×
Academic Journal

Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma.

  • Authors : Vikram; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.; Kumar S

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy

  • Source: Assay and drug development technologies [Assay Drug Dev Technol] 2024 Feb-Mar; Vol. 22 (2), pp. 73-85. Date of Electronic Publication: 2024 Jan 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

×
Academic Journal

Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the PI3K / AKT Pathway.

  • Authors : Wang D; Department of Neurosurgery, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, People's Republic of China.; Wang Z

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics ; Glioma*/Glioma*/Glioma*/genetics; Humans

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Mar; Vol. 39 (2), pp. 125-132. Date of Electronic Publication: 2021 Jan 20.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Preserved White Matter Integrity and Recovery After Brain Tumor Surgery: A Prospective Pilot Study on the Frontal Aslant Tract.

  • Authors : Wende T; Department of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.; Hoffmann A

Subjects: White Matter*/White Matter*/White Matter*/diagnostic imaging ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/surgery

  • Source: Brain connectivity [Brain Connect] 2023 Dec; Vol. 13 (10), pp. 589-597. Date of Electronic Publication: 2023 Oct 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101550313 Publication Model: Print-Electronic

Record details

×
Academic Journal

Nicotinamide Adenine Dinucleotide Phosphate Oxidase Promotes Glioblastoma Radiation Resistance in a Phosphate and Tensin Homolog-Dependent Manner.

  • Authors : Ludwig K; The Intellectual and Developmental Disabilities Research Center and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Le Belle JE

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioblastoma*/Glioblastoma*/Glioblastoma*/radiotherapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Nov; Vol. 39 (13-15), pp. 890-903. Date of Electronic Publication: 2023 Oct 25.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

Metabolomic Profiles of Human Glioma Inform Patient Survival.

  • Authors : Scott AJ; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Department of Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.

Subjects: Glioma*/Glioma*/Glioma*/genetics ; Glioma*/Glioma*/Glioma*/metabolism ; Astrocytoma*/Astrocytoma*/Astrocytoma*/genetics

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Nov; Vol. 39 (13-15), pp. 942-956. Date of Electronic Publication: 2023 Apr 27.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance.

  • Authors : Bailleul J; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.; Vlashi E

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Nov; Vol. 39 (13-15), pp. 957-979. Date of Electronic Publication: 2023 Apr 05.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

Tumor Niches: Perspectives for Targeted Therapies in Glioblastoma.

  • Authors : Srivastava R; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; John G. Rangos Sr. Research Center, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioma*

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Nov; Vol. 39 (13-15), pp. 904-922. Date of Electronic Publication: 2023 Jun 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

Correlation Between Oligometastatic Tumor in Two Other Visceral Organs and Prognosis in Patients With Brain Metastases.

  • Authors : Ampil F; Department of Radiology and Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.; Porter C

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/therapy ; Radiosurgery*; Humans

  • Source: Journal of palliative medicine [J Palliat Med] 2023 Dec; Vol. 26 (12), pp. 1715-1718. Date of Electronic Publication: 2023 Nov 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9808462 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  173 results for ""Brain Neoplasms""